Feb 26 (Reuters) - Clayton Dubilier & Rice LLC has amassed $6.25 billion for its latest flagship private equity fund after it got oversubscribed, turning down as much as $2 billion from investors, ...

Clayton, Dubilier & Rice LLC affiliates have agreed to pay $70 million to end shareholder litigation targeting their $4 billion deal for Covetrus Inc.

Clayton Dubilier & Rice made it a condition for banks to commit more than €1 billion ($1.1 billion) of debt to fund a part of the equity check for its bid for Sanofi’s consumer-health division, though ...

(Reuters) - U.S. private equity firm Clayton Dubilier & Rice (CD&R) said on Tuesday it had agreed to acquire a majority ownership position in information technology provider Presidio from UK-based BC ...

Sanofi and CD&R enter exclusive talks to sell a 50% stake in Opella, Sanofi's consumer health unit, valued at $17.4 billion. Opella serves over 500M consumers globally with top brands like Allegra and ...

Last week, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business. The deal could be ...

Clayton Dubilier & Rice is discussing the possibility of using borrowed money to fund a part of the equity check in its bid for Sanofi’s €15 billion ($16.6 billion) consumer health division, according ...